#tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity First Time Tirzepatide - Neo

It works by targeting three hormone pathways involved in appetite regulation, energy use, and metabolism, which is why its often described as a triple-agonist therapy

Central infusion of insulin-like growth factor-1 increases hippocampal neurogenesis and improves neurobehavioral function after traumatic brain injury

The approval was granted based on demonstrated improvements in MASH and fibrosis, and a confirmatory study is currently underway

Clover Meds focuses on injectable compounded options for patients in four states, with a synchronous, dedicated-provider model

By 8 to 12 weeks, most participants experience 5 to 15 pounds of loss depending on baseline body weight, starting dose, and adherence

It supports mitochondrial function, DNA repair, and energy metabolism